Access to $16K postpartum depression pill an 'uphill battle'

A breakthrough drug to treat postpartum depression is making headlines more for its lofty price than its anticipated remedy.

Related Keywords

,Sarah Oreck ,Katrina Furey ,Reuters ,Yale School Of Medicine ,Mavida Health ,Sage Therapeutics ,Yale School ,Women 039s Health ,Health ,Parenting ,Moms ,Pharmaceuticals ,Postpartum Depression ,Pregnancy ,